Skip to content 
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. Medline Inc. was founded in 1966 and is based in Northfield, Illinois. more
| Dec '22 | Dec '23 | Dec '24 | ||||
|---|---|---|---|---|---|---|
| Total Revenue | 21.45B | 23.23B | 25.51B | [{"date":"2022-12-31","value":84.09,"profit":true},{"date":"2023-12-31","value":91.08,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Cost of Revenue | 16.89B | 18.01B | 19.22B | [{"date":"2022-12-31","value":87.9,"profit":true},{"date":"2023-12-31","value":93.71,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Gross Profit | 4.56B | 5.22B | 6.29B | [{"date":"2022-12-31","value":72.44,"profit":true},{"date":"2023-12-31","value":83.02,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Gross Margin | 21.25% | 22.48% | 24.66% | [{"date":"2022-12-31","value":86.15,"profit":true},{"date":"2023-12-31","value":91.16,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Operating Expenses | 3.69B | 3.78B | 4.07B | [{"date":"2022-12-31","value":90.68,"profit":true},{"date":"2023-12-31","value":92.94,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Operating Income | 870.00M | 1.44B | 2.23B | [{"date":"2022-12-31","value":39.1,"profit":true},{"date":"2023-12-31","value":64.9,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Total Non-Operating Income/Expense | - | - | - | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | ||
| Pre-Tax Income | 10.00M | 264.00M | 1.25B | [{"date":"2022-12-31","value":0.8,"profit":true},{"date":"2023-12-31","value":21.19,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Income Taxes | 35.00M | 30.00M | 46.00M | [{"date":"2022-12-31","value":76.09,"profit":true},{"date":"2023-12-31","value":65.22,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| Income After Taxes | - | - | - | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | ||
| Income From Continuous Operations | - | - | - | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | ||
| Income From Discontinued Operations | - | - | - | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | ||
| Net Income | (25.00M) | 234.00M | 1.20B | [{"date":"2022-12-31","value":-2.08,"profit":false},{"date":"2023-12-31","value":19.5,"profit":true},{"date":"2024-12-31","value":100,"profit":true}] | ||
| EPS (Diluted) | - | - | - | [{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}] | ||
These ratios help you determine the liquidity of the company. Higher is better.
| MDLN | |
|---|---|
| Cash Ratio | 0.37 |
| Current Ratio | 3.66 |
| Quick Ratio | 1.84 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| MDLN | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| MDLN | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.54 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.46 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| MDLN | |
|---|---|
| Trailing PE | 62.40 |
| Forward PE | 28.99 |
| P/S (TTM) | 1.24 |
| P/B | 265.57 |
| Price/FCF | 63 |
| EV/R | 1.80 |
| EV/Ebitda | 15.42 |
Medline Inc. Class A Common Stock (MDLN) share price today is $49.79
Yes, Indians can buy shares of Medline Inc. Class A Common Stock (MDLN) on Vested. To buy
Yes, you can purchase fractional shares of Medline Inc. Class A Common Stock (MDLN) via the Vested app. You can start investing in Medline Inc. Class A Common Stock (MDLN) with a minimum investment of $1.
You can invest in shares of Medline Inc. Class A Common Stock (MDLN) via Vested in three simple steps:
The 52-week high price of Medline Inc. Class A Common Stock (MDLN) is $68. The 52-week low price of Medline Inc. Class A Common Stock (MDLN) is $29.
The price-to-earnings (P/E) ratio of Medline Inc. Class A Common Stock (MDLN) is 62.3986
The price-to-book (P/B) ratio of Medline Inc. Class A Common Stock (MDLN) is 265.57
The dividend yield of Medline Inc. Class A Common Stock (MDLN) is 0.00%
The market capitalization of Medline Inc. Class A Common Stock (MDLN) is $39.61B
The stock symbol (or ticker) of Medline Inc. Class A Common Stock is MDLN
Consider the share price of Medline Inc. Class A Common Stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Medline Inc. Class A Common Stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Medline Inc. Class A Common Stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Medline Inc. Class A Common Stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Medline Inc. Class A Common Stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Medline Inc. Class A Common Stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
